Nitai Mukhopadhyay

5PUBLICATIONS
30CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 10, 2026
Disease-Duration-Specific Percentiles for Prospective Subtyping of Parkinson's Disease: A PPMI-Based Study.

|Sep 18, 2023
Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.

Anjan K Pradhan, Jinkal Modi, Santanu Maji

|Sep 12, 2023
Melatonin Supplementation for Cancer-Related Fatigue in Patients With Early Stage Breast Cancer Receiving Radiotherapy: A Double-Blind Placebo-Controlled Trial.

Nitai D Mukhopadhyay, Adam Khorasanchi, Sudeep Pandey

|Mar 22, 2022
Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.

Andrea N Riner, Selamawit Girma, Vignesh Vudatha

|Aug 25, 2019
Identifying Attrition Phases in Survey Data: Applicability and Assessment Study.

Camille J Hochheimer, Roy T Sabo, Robert A Perera

Pageof 1

Frequent Collaborators

1 joint publications

Anjan K Pradhan

1 joint publications

Jinkal Modi

1 joint publications

Santanu Maji

1 joint publications

Amit Kumar